Mai Capital Management Axogen, Inc. Transaction History
Mai Capital Management
- $13 Billion
- Q1 2025
A detailed history of Mai Capital Management transactions in Axogen, Inc. stock. As of the latest transaction made, Mai Capital Management holds 68 shares of AXGN stock, worth $763. This represents 0.0% of its overall portfolio holdings.
Number of Shares
68
Previous 129
47.29%
Holding current value
$763
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AXGN
# of Institutions
191Shares Held
39.2MCall Options Held
61.7KPut Options Held
42.8K-
First Light Asset Management, LLC Edina, MN4.47MShares$50.2 Million10.62% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$36.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.6MShares$29.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$28.5 Million0.0% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO1.59MShares$17.9 Million0.54% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $475M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...